Skip to Content

Patients with Pediatric-Onset Immune-Mediated Inflammatory Diseases Have a Four-Times Increased Risk of Dying

The aim of this study was to estimate the effect of pediatric-onset immune-mediated inflammatory diseases on the risk of all-cause and cause-specific mortality to see if there are similar trends in the other disease groups that have been reported for patients with pediatric-onset inflammatory bowel disease. Listen to Sabine Jansson in this MEDtalk about the study that was presented at the ECCO Congress 2024.

Sabine Jansson

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top